Untitled

Simphotek | Medical Devices

  • Home

  • Technology

    • Dosie
    • PEDSy
    • Intelli
  • IP

    • Publications
  • Clinical Trials

  • News

  • Team

    • Advisory Board
  • FCOI

  • More

    Use tab to navigate through the menu items.
    Contact

    Our Recent Posts

    Dr. Mary Potasek presents on the topics of LALC and ACAO PDT clinical trials

    Dr. Mary Potasek presents on the topics of LALC and ACAO PDT clinical trials

    Simphotek partners with Penn in fighting Mesothelioma

    Simphotek partners with Penn in fighting Mesothelioma

    Simphotek welcomes Dr. Abraham Wu as a new Scientific Advisory Board member.

    Simphotek welcomes Dr. Abraham Wu as a new Scientific Advisory Board member.

    Archive

    • November 2021
    • April 2021
    • October 2020
    • September 2020
    • August 2020
    • November 2019
    • July 2019
    • January 2019
    • January 2017
    • May 2016
    • April 2016
    • March 2016
    • January 2016
    • October 2015

    Tags

    • Blog
    • Cancer treatment
    • Dosie
    • Dosimetry
    • Dosimetry device
    • Dosimetry platform
    • Dosimetry software
    • EDA CCIT
    • EDC Summit
    • Endobronchial cancer
    • Esophageal cancer
    • FRAC
    • Head and Neck cancer
    • HealthTech Conference
    • HPPH
    • I-PDT
    • Intelli
    • Intracavitary PDT
    • Investor conference
    • IPA
    • Locally-advanced cancers
    • MedTech
    • Mesothelioma
    • mice
    • NCI
    • New cancer treatments
    • New Jersey’s Founders & Funders
    • NIH grant
    • NJ
    • NJ Tech Concil
    • NJBiz
    • NJTC
    • PDT
    • PDT planning and monitoring
    • PDT-dose
    • PEDSy
    • Pitch
    • Presentation
    • Reacted singlet oxygen dose
    • Real-time dosimetry
    • Women in Business
    • Workshop
    Simphotek honored as a Finalists by Onelin Capital
    Mary
    • Sep 22, 2020

    Simphotek honored as a Finalists by Onelin Capital

    Simphotek, Inc. has been selected as one of 20 company Finalist to pitch to Onelin Capital and 400+ global early-stage investors Onelin Capital, A multi-billion dollar global conglomerate seeking startups in the life sciences Each company presented a 4-minute prerecorded pitch video, a 1-minute elevator-pitch, and participated in a live Q&A session with a panel of the sponsor and relevant investors.
    Mary
    • Sep 17, 2020

    Simphotek selected as one of 5 Featured Company at Digital RESI

    Simphotek, Inc, a leading edge biotech company, developing noninvasive personalized products for treating internal solid tumors, was selected as a featured company and presented to a group of investors including MedPro Investors TiE Boston Angels Meda Angels Orange Grove Bio Accent Advisors

    Follow

    • Twitter
    • LinkedIn
    • Facebook

    Contact

    info@simphotek.com

    (973) 621-2340

    Address

    211 Warren St, Newark, NJ 07103, USA

    ©2021 by Simphotek Inc.